01 Stock Market
U.S. stock index futures edged higher, with gains led by tech-heavy benchmarks. E-mini Dow futures rose 0.49% to 49100, E-mini S&P 500 futures climbed 0.5% to 6924.75, and E-mini Nasdaq 100 futures advanced 0.56% to 25612. Strength in growth and semiconductor-linked names indicates investors are prioritizing AI and auto-tech catalysts into the open, while broader macro sensitivity remains anchored in rate and dollar moves heading into a busy data week.
Notable Stock Movers: mega-cap tech, autos, and semis saw pre-market strength. TSLA up 1.06% at $463.84; NVDA up 1.14% at $177.02; MU up 2.07% at $246.12; AVGO up 0.77% at $362.71; AMD up 0.81% at $212.49; GOOG up 0.69% at $312.66; META up 0.47% at $646.75; AMZN up 0.48% at $227.27; NFLX up 0.76% at $95.91; QQQ up 0.57% at $617.10. Precious-metals proxies outperformed: AGQ up 5.31% at $132.06; SLV up 2.94% at $57.75; and UGL up 1.90% at $56.79. Software lagged: ORCL fell 0.42% at $189.17.
Tech and auto-related catalysts are driving early leadership, with semis and AI-linked exposures firm and EV momentum supported by autonomy developments. Meanwhile, precious metals and their leveraged ETFs gained as gold prices strengthened, contributing to diversified risk-on positioning. Select software and cyclical laggards remain sensitive to deal headlines and product pipeline visibility.
02 Other Markets
10-year U.S. Treasury yield fell 0.80%, to 4.16%.
U.S. Dollar Index fell 0.12% to 98.28.
WTI crude oil futures fell 0.59% to 57.10 USD/barrel; COMEX gold futures rose 1.06% to 4374.10 USD/ounce.
03 Key News
iRobot filed Chapter 11 and agreed to a restructuring deal to become private under Shenzhen Picea Robotics and Santrum Hong Kong, sending IRBT down about 80% pre-market. The company said the transaction will strengthen its finances and ensure continuity for customers and partners. iRobot plans to delist and operate as a wholly owned entity following court approval.
Tesla began driverless Robotaxi testing in Austin, with Model Y units operating without occupants, supporting autonomy progress and lifting TSLA about 1% pre-market. The company is working to remove Safety Monitors and expand driverless rides, with early trials focused on central Austin neighborhoods. The effort underscores Tesla’s push to scale autonomous services and its broader AI roadmap.
ServiceNow entered talks to acquire cybersecurity firm Armis in a potential deal near $7 billion, highlighting a push into security software adjacency. The reported discussions reflect strategic expansion into cyber defense, potentially deepening workflow integrations for enterprise clients. Investors will watch for confirmation and financing details as large-cap software weighs growth versus margin discipline.
Coinbase plans to launch prediction markets and tokenized equities as part of an “everything app” push, expanding on-chain financial use-cases. Tokenized stocks are slated to be built in-house, aligning with Coinbase’s effort to broaden product reach and utility. The move targets new revenue streams and deeper engagement with retail and institutional users across regulated digital asset rails.
SpaceX set a secondary share sale reportedly valuing the company near $800 billion, spotlighting private-market demand and potential knock-on effects for satellite-linked equities such as EchoStar (SATS). Investor focus is on Starlink’s subscriber growth and future AI-in-space concepts flagged by Elon Musk. Public proxies with exposure to SpaceX assets may react as new valuation marks emerge and IPO chatter intensifies.
Robinhood tokenized stocks on Arbitrum, with tokenized market value recently surpassing $13 million, signaling continued convergence of TradFi and DeFi. Management highlighted Ethereum’s security and Arbitrum’s engineering flexibility as enabling infrastructure. The initiative aims to expand access, settlement efficiency, and programmable finance use-cases across tokenized assets.
Sanofi reported a late-stage multiple sclerosis trial failure and an FDA review delay for tolebrutinib, leading SNY to fall around 4–5% in U.S. pre-market trading. The company said it would not pursue approval in primary progressive MS, about a tenth of the MS population. Development challenges and safety concerns have complicated timelines, increasing scrutiny on pipeline risk management.
Tesla Full Self-Driving version 14 gained favorable third-party reviews, with tracked disengagements improving notably, reinforcing the autonomous roadmap. Crowd-sourced metrics indicate smoother driving behavior and fewer critical interventions versus prior builds. While regulatory approval for eyes-off autonomy remains pending, enhanced performance supports the commercial path to robotaxi scaling.
Sources: Reuters, Dow Jones, Tiger Newspress, public market data
Disclaimer: For informational purposes only; not investment advice.
